Boston, MA 06/04/2013 (wallstreetpr) – The share prices of TearLab Corporation (NASDAQ:TEAR) had surged by 9.03 percent to close at $11.47 per share for the end of last trading session on Monday. The shares of the company had gained by $0.95 per share over the previous closing price on Friday. The shares of an in – vitro diagnostic company had been trading in the range of $11.06 to $11.98 per share during the day. With the recent surge in share prices, TearLab Corporation (NASDAQ:TEAR) had hit new 52 week high price levels at $11.98 per share and the 52 week low price level of the company is at $2.75 per share.
TearLab Corporation (NASDAQ:TEAR) is involved in the design, development and commercialization of its principal tear testing platform which is named the TearLab Osmolarity System. This testing system enables the eye care practitioners to diagnose for the presence of sensitive and specific biomarkers at the point of care of the patients using nanoliters of tear film. The three major components involved in the testing system are TearLab Disposable, TearLab Reader and TearLab Pen.
The shares of TearLab Corporation (NASDAQ:TEAR) had recently been surging to new high levels touching new peaks everyday for the past few days. Further, the trading volume in the shares of the in vitro diagnostic firm had also been very high compared to the average trading volume of 505,294 shares per day.
TearLab Corporation (NASDAQ:TEAR) presently holds 28.77 million shares outstanding in the market with an institutional ownership of 44 percent of its holdings.
